- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Mark Friedberg on Achieving Professional Satisfaction in the Practice
In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
In the last few years, there’s been a real surge in interest in professional satisfaction in healthcare, according to Mark Friedberg, MD, MPP, senior natural scientist and director of the Boston office at RAND Corporation.
Transcript
What larger initiatives are in place to address physician satisfaction and what do they hope to achieve?
In terms of large initiatives, in the last few years there’s been a real surge in interest in professional satisfaction in clinicians, physicians, and other types of clinicians as well. The American Medical Association, for example, has some efforts in place that are freely available to physician practices around the country. And these are general ideas on how to restructure in your practice to make it more durable basically.
There are also some what I call symptomatic treatments that have become popular like mindfulness training and other things that sort of like treat the symptom but not the cause. So like bringing tea or snacks around to people to make them feel appreciated in the practice. I do worry about that second category of popular approaches to professional satisfaction. The ones that are like mindfulness and the tea and you know appreciation letters. Those might be a cover up of underlying problems and you might be able to get a little bit of improvement in professional satisfaction without addressing any of the underlying issues and I do worry that that wouldn’t be a very good approach for people to take if on the other hand they could be addressing some underlying issues and getting a bump in professional satisfaction instead.
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Refining Precision Prevention for Benign Breast Disease
December 7th 2023Many questions remain surrounding accurately classifying the risk of developing invasive breast cancer associated with the benign breast disease diagnoses of nonproliferative lesions and proliferative changes without atypia.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
ASH 2023 to Highlight Options in Care for Blood Diseases—for Those Who Have Access
December 7th 2023The 65th American Society of Hematology (ASH) Annual Meeting & Exposition, which runs Friday through Tuesday in the San Diego Convention Center, will showcase the growing number of treatment choices in blood cancers and disorders.
Read More
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
